Sunday November 8 2009 | Biotechnology feed | All feeds
|
|
Vaccinex Incorporated
Download detailed PDF Members: Founded in 1997, Vaccinex is a privately owned biotechnology company developing treatments that harness the power of the body's immune system to fight cancer and other diseases. Vaccinex's novel core technology represents a significant advance in gene discovery technology as it permits the efficient selection of individual genes associated with specific biological processes, even in circumstances in which other methods fail. This technology is proprietary to Vaccinex and offers diverse applications including: antigen identification, human monoclonal antibody ("MAb") selection, and functional gene discovery. Vaccinex is leveraging these technologies to develop its own antibody and vaccine-based therapeutics and has also begun marketing its Human Antibody Selection Technology to other biopharmaceutical companies with their own proprietary targets.
This page has been viewed 770 times since April 2007, the link to the organisation's website has been followed 145 times Recent Search Terms used to find this page: vaccinex | vaccinex | vaccinex | vaccinex | vaccinex | . Search for more companies in Rochester Search for more companies in NY This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Vaccinex Incorporated | ||||||||||||||||||||||||||||||||||||||
|